Wasatch BioLabs adds three Oxford Nanopore-developed research-use-only assays to service portfolio

GSK and IQVIA expand vaccine track with local data to drive targeted public health action

Appili Therapeutics and Vitalex Biosciences secure NIAID contract for fungal vaccine development for up to USD40m

AstraZeneca launches online platform to expand patient access to medications

Dr Eric Berg Joins Forces with Robert F. Kennedy Jr. to Advocate for Transparency in Vaccine Science and Public Health

Sanofi increases Sanofi Ventures funding by USD625m to boost biotech and digital health investments

GC Biopharma submits IND application in South Korea for Phase 1 trial of COVID-19 vaccine candidate

AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137

LakeShore Biopharma receives Nasdaq delisting determination letter

Anixa Biosciences completes dosing of fourth cohort in ovarian cancer CAR-T trial; Early results show promise

ExpreS2ion reports early immune response in first patient from Phase I HER2 breast cancer vaccine trial

Valneva reports strong Phase 2 booster results for Lyme disease vaccine candidate VLA15

GC Biopharma files IND for Phase 3 trial of BARYCELA in Thailand

Novavax COVID-19 vaccine approved in US

WHO and UNICEF deploy PharmaJet's Tropis ID system in Afghanistan polio campaign